Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease

Marta Cano-Megías1, Hanane Bouarich1, Pablo Guisado-Vasco2

  • 1Unidad de Nefrología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España.

Insights

Patients with advanced chronic kidney disease (CKD) and diabetes mellitus (DM) exhibit more severe coronary artery calcification (CaC) and higher mortality rates. This highlights the critical link between these conditions and cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Background:

  • Patients with chronic kidney disease (CKD) and diabetes mellitus (DM) face elevated cardiovascular risk due to shared pathways of atherosclerosis and vascular calcification.
  • Coronary artery calcification (CaC) is more prevalent and severe in diabetic patients, irrespective of kidney function.
  • Limited data exists on the long-term prognostic implications of CaC in diabetic individuals with CKD.

Purpose of the Study:

  • To investigate the association between coronary artery calcification (CaC) and long-term mortality in patients with advanced chronic kidney disease (CKD).
  • To compare the severity of CaC and mortality rates between diabetic and non-diabetic patients with advanced CKD.

Main Methods:

  • A prospective longitudinal study included 137 patients with advanced CKD.
  • Coronary computed tomography (CT) was used to assess coronary artery calcification (CaC) using the Agatston score.
  • Patients were categorized into severe (CaCs≥400HU) and mild-moderate (CaCs<400HU) calcification groups.

Main Results:

  • Diabetes mellitus (DM) was present in 28% of subjects, associated with more severe CaC, lower albumin, and higher C-reactive protein.
  • Serum albumin levels correlated with severe CaC (r=-0.45, P=.009).
  • Overall mortality was 58%; diabetic patients showed higher mortality, particularly those with severe CaC (93% vs. 73% in non-diabetics, P=.04).

Conclusions:

  • Advanced CKD patients with DM demonstrate more severe coronary artery calcification (CaC).
  • These patients exhibit increased markers of inflammation and malnutrition.
  • The presence of both advanced CKD and DM is linked to significantly higher long-term mortality.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
736
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
270
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
651